Endocrinology & Metabolism

Prevalence of metabolic associated fatty liver disease is increasing

The percent of metabolic associated fatty liver disease (MAFLD), the leading global cause of liver disease, is increasing in U.S. adults, according to a study presented Friday at ENDO 2023, the Endocrine Society's annual ...

Medications

England eyes expanding access to weight-loss drugs

Doctors in England's state-run health service could soon be allowed to prescribe more people with obesity weight-loss drugs under a new pilot scheme, the government said Wednesday.

page 30 from 40